Advanced technologies in biopharmaceutical processing.9780813805177 Advanced technologies in biopharmaceutical processing. Ed. by Roshni L. Dutton and Jeno M. Scharer. Blackwell Publishing 2007 284 pages $199.99 Hardcover RS192 Dutton (president, Bioprocess bi·o·proc·ess n. 1. A technique that produces a biological material, such as a genetically engineered microbial strain, for commercial use. 2. Assist, Canada) and Scharer (chemical engineering, U. of Waterloo Waterloo, town, Belgium Waterloo (vä`tərlō), commune (1991 pop. 27,860), Walloon Brabant prov., central Belgium, near Brussels. The battle of Waterloo (see Waterloo campaign) was fought just south of there on June 18, 1815. , Canada) provide an overview of advanced an emerging pharmaceutical manufacturing technologies for an audience ranging from novice technical staff with no manufacturing experience to biopharmaceutical professionals expert in just a few production areas. Following an introduction to the industry, chapters cover regulatory requirements Regulatory requirements are part of the process of drug discovery and drug development. Regulatory requirements describe what is necessary for a new drug to be approved for marketing in any particular country. for processing biopharmaceuticals; the impact of genomics, proteomics, and metabolomics on biopharmaceutical processing; new technologies in biopharmaceutical upstream and downstream processing Downstream processing refers to the recovery and purification of biosynthetic products, particularly pharmaceuticals, from natural sources such as animal or plant tissue or fermentation broth, including the recycling of salvageable components and the proper treatment and disposal ; biopharmaceutical product formulation, preservation, and presentation; biopharmaceutical process monitoring, analysis, and control; discrete automation in bioprocessing unit operations Unit operations A structure of logic used for synthesizing and analyzing processing schemes in the chemical and allied industries, in which the basic underlying concept is that all processing schemes can be composed from and decomposed into a series of ; and emerging biopharmaceutical platforms. ([c]20072005 Book News, Inc., Portland, OR) |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion